Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net earnings $ 585 $ 302
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 264 189
Stock compensation expense 99 112
Deferred income taxes (32) (17)
Changes in assets and liabilities    
Premium and related receivables (749) (906)
Other assets (39) 7
Medical claims liabilities 406 15
Unearned revenue 255 301
Accounts payable and accrued expenses 205 99
Other long-term liabilities 45 156
Other operating activities, net 0 1
Net cash provided by operating activities 1,039 259
Cash flows from investing activities:    
Capital expenditures (301) (211)
Purchases of investments (1,720) (1,528)
Sales and maturities of investments 1,335 955
Investments in acquisitions, net of cash acquired 0 (848)
Net cash used in investing activities (686) (1,632)
Cash flows from financing activities:    
Proceeds from long-term debt 1,170 6,956
Payments of long-term debt (1,124) (4,257)
Common stock repurchases (18) (29)
Purchase of noncontrolling interest (33) (14)
Debt issuance costs 0 (59)
Other financing activities, net 2 (3)
Net cash (used in) provided by financing activities (3) 2,594
Effect of exchange rate changes on cash and cash equivalents 1 1
Net increase in cash and cash equivalents 351 1,222
Cash and cash equivalents, beginning of period 3,930 1,760
Cash and cash equivalents, end of period 4,281 2,982
Supplemental disclosures of cash flow information:    
Interest paid 210 113
Income taxes paid 358 394
Equity issued in connection with acquisitions $ 0 $ 3,105